TrialPloS one2015

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

Steven F L van Lelyveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.